Insider · CIK 0001829360

Ege David S.

Reports to the SEC for 1 company · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001829360

Forms 4 and 5

Insider transactions

25 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-08-16	MCRBSeres Therapeutics, Inc.S Sale	See Remarks	SSale	−1,128 sh	$0.84	−$947.52	77,575
2024-08-15	MCRBSeres Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,969 sh	—	—	78,703
2024-08-15	MCRBSeres Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−2,969 sh	—	—	29,688
2024-05-15	MCRBSeres Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+2,968 sh	—	—	76,824
2024-05-15	MCRBSeres Therapeutics, Inc.S Sale	See Remarks	SSale	−1,090 sh	$0.94	−$1,024.6	75,734
2024-05-15	MCRBSeres Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−2,968 sh	—	—	32,657
2024-02-16	MCRBSeres Therapeutics, Inc.S Sale	See Remarks	SSale	−5,010 sh	$1.08	−$5,410.8	73,856
2024-02-15	MCRBSeres Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+11.9K sh	—	—	78,866
2024-02-15	MCRBSeres Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−11.9K sh	—	—	35,625
2024-02-14	MCRBSeres Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+188K sh	—	—	187,500
2024-02-14	MCRBSeres Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+288K sh	—	—	287,905
2024-02-14	MCRBSeres Therapeutics, Inc. · Restricted Stock UnitsA Award	See Remarks	AAward	+31.3K sh	—	—	31,250
2023-10-30	MCRBSeres Therapeutics, Inc.S Sale	See Remarks	SSale	−4,066 sh	$1.35	−$5,489.1	66,991
2023-10-27	MCRBSeres Therapeutics, Inc.M Exercise/Conversion	See Remarks	MExercise/Conversion	+11.4K sh	—	—	71,057
2023-10-27	MCRBSeres Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	See Remarks	MExercise/Conversion	−11.4K sh	—	—	11,360
2023-04-28	MCRBSeres Therapeutics, Inc.S Sale	See Remarks	SSale	−7,038 sh	$5.19	−$36.5K	59,696
2023-04-27	MCRBSeres Therapeutics, Inc.A Award	See Remarks	AAward	+20K sh	—	—	66,734
2023-04-27	MCRBSeres Therapeutics, Inc. · Restricted Stock UnitsA Award	See Remarks	AAward	+22.7K sh	—	—	22,721
2023-02-03	MCRBSeres Therapeutics, Inc. · Restricted Stock UnitsA Award	See Remarks	AAward	+47.5K sh	—	—	47,500
2023-02-03	MCRBSeres Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+95K sh	—	—	95,000
2022-10-31	MCRBSeres Therapeutics, Inc.S Sale	See Remarks	SSale	−5,012 sh	$7.93	−$39.7K	46,734
2022-10-27	MCRBSeres Therapeutics, Inc.A Award	See Remarks	AAward	+20K sh	—	—	51,746
2022-07-05	MCRBSeres Therapeutics, Inc.A Award	See Remarks	AAward	+31.7K sh	$3.15	+$100K	31,746
2022-02-04	MCRBSeres Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+175K sh	—	—	175,000
2020-10-19	MCRBSeres Therapeutics, Inc. · Stock Option (Right to Buy)A Award	See Remarks	AAward	+200K sh	—	—	200,000

Recent filings

Accepted (ET)
Aug 194
Ege David S.0000950170-24-098699
SEC(opens sec.gov)
May 174
Ege David S.0000950170-24-062056
SEC(opens sec.gov)
Feb 164
Ege David S.0000950170-24-016688
SEC(opens sec.gov)
Oct 314
Ege David S.0000899243-23-020075
SEC(opens sec.gov)
May 14
Ege David S.0000899243-23-011945
SEC(opens sec.gov)
Feb 74
Ege David S.0000899243-23-004211
SEC(opens sec.gov)

Companies

Seres Therapeutics, Inc.See RemarksMCRB

Address

C/O SERES THERAPEUTICS, INC. 200 SIDNEY STREET

CAMBRIDGE, MA, 02139